Medifron DBT Co., Ltd. announced that it has received KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.

Hyper Corporation Inc, formerly Medifron DBT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of information and communication devices. The Company operates through three segments. The Information and Communication Technology Business segment is engaged in the manufacture and sale of gaming mice, gaming monitors, televisions, routers, and gaming devices. The Home Meal Replacement segment is engaged in the manufacture and supply of convenient meals. The New Drug Business segment is engaged in the development and sales of Alzheimer's treatments, non-narcotic painkillers, and early diagnosis kits for dementia.